| KEGG pathway | renal cell carcinoma, HSA05211; gnrh signaling pathway, HSA04912; endometrial cancer, HSA05213; gap junction, HSA04540; melanogenesis, HSA04916; natural killer cell mediated cytotoxicity, HSA04650; toll like receptor signaling pathway, HSA04620; non small cell lung cancer, HSA05223; thyroid cancer, HSA05216; regulation of actin cytoskeleton, HSA04810; melanoma, HSA05218; acute myeloid leukemia, HSA05221; glioma, HSA05214; long term potentiation, HSA04720; fc epsilon ri signaling pathway, HSA04664; insulin signaling pathway, HSA04910; mapk signaling pathway, HSA04010; prostate cancer, HSA05215; erbb signaling pathway, HSA04012; bladder cancer, HSA05219; vegf signaling pathway, HSA04370; chronic myeloid leukemia, HSA05220; long term depression, HSA04730 |
|---|
| NCI pathway | Signaling events mediated by Stem cell factor receptor (c-Kit), kitpathway; Netrin-mediated signaling events, netrin_pathway; Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met), met_pathway; SHP2 signaling, shp2_pathway; ErbB2/ErbB3 signaling events, erbb2erbb3pathway; Downstream signaling in na&, xef;ve CD8+ T cells, cd8tcrdownstreampathway; GMCSF-mediated signaling events, gmcsf_pathway; Cellular roles of Anthrax toxin, anthraxpathway; IL2-mediated signaling events, il2_1pathway; Nongenotropic Androgen signaling, ar_nongenomic_pathway; ErbB1 downstream signaling, erbb1_downstream_pathway; PDGFR-beta signaling pathway, pdgfrbpathway; Endothelins, endothelinpathway; CXCR3-mediated signaling events, cxcr3pathway; Fc-epsilon receptor I signaling in mast cells, fcer1pathway; Signaling events mediated by VEGFR1 and VEGFR2, vegfr1_2_pathway; Ceramide signaling pathway, ceramide_pathway; mTOR signaling pathway, mtor_4pathway |
|---|
| WIKI pathway | Focal Adhesion(Mus musculus), WP85; Nanoparticle-mediated activation of receptor signaling(Homo sapiens), WP2643; MAPK Cascade(Homo sapiens), WP422; Insulin Signaling(Homo sapiens), WP481; IL-6 signaling pathway(Homo sapiens), WP364; Leptin signaling pathway(Homo sapiens), WP2034; TCR Signaling Pathway(Homo sapiens), WP69; IL-9 Signaling Pathway(Mus musculus), WP10; IL-5 Signaling Pathway(Mus musculus), WP151; Regulation of Actin Cytoskeleton(Mus musculus), WP523; Amyotrophic lateral sclerosis (ALS)(Homo sapiens), WP2447; MAPK signaling pathway(Mus musculus), WP493; BDNF signaling pathway(Homo sapiens), WP2380; Focal Adhesion(Homo sapiens), WP306; Structural Pathway of Interleukin 1 (IL-1)(Homo sapiens), WP2637; Serotonin Receptor 4/6/7 and NR3C Signaling(Homo sapiens), WP734; IL-7 Signaling Pathway(Mus musculus), WP297; Signaling Pathways in Glioblastoma(Homo sapiens), WP2261; IL-7 Signaling Pathway(Homo sapiens), WP205; Oncostatin M Signaling Pathway(Homo sapiens), WP2374; Integrin-mediated Cell Adhesion(Mus musculus), WP6; EGFR1 Signaling Pathway(Mus musculus), WP572; EGF/EGFR Signaling Pathway(Homo sapiens), WP437; MAPK Cascade(Mus musculus), WP251; Regulation of Actin Cytoskeleton(Homo sapiens), WP51; IL-5 Signaling Pathway(Homo sapiens), WP127; IL-9 Signaling Pathway(Homo sapiens), WP22; EPO Receptor Signaling(Mus musculus), WP1249; Insulin Signaling(Mus musculus), WP65; MicroRNAs in Cardiomyocyte Hypertrophy(Mus musculus), WP1560; TSLP Signaling Pathway(Homo sapiens), WP2203; Hypothetical Network for Drug Addiction(Mus musculus), WP1246; IL-2 Signaling Pathway(Homo sapiens), WP49; Integrin-mediated Cell Adhesion(Homo sapiens), WP185; Serotonin Receptor 2 and ELK-SRF/GATA4 signaling(Homo sapiens), WP732; Kit receptor signaling pathway(Homo sapiens), WP304; Toll-like receptor signaling pathway(Homo sapiens), WP75; MicroRNAs in cardiomyocyte hypertrophy(Homo sapiens), WP1544; B Cell Receptor Signaling Pathway(Homo sapiens), WP23; IL-6 signaling Pathway(Mus musculus), WP387; MAPK Signaling Pathway(Homo sapiens), WP382; Cardiac Hypertrophic Response(Homo sapiens), WP2795; Regulation of toll-like receptor signaling pathway(Homo sapiens), WP1449; EPO Receptor Signaling(Homo sapiens), WP581; Signaling of Hepatocyte Growth Factor Receptor(Homo sapiens), WP313; ESC Pluripotency Pathways(Mus musculus), WP339; Signaling of Hepatocyte Growth Factor Receptor(Mus musculus), WP193; IL-1 signaling pathway(Homo sapiens), WP195; XPodNet - protein-protein interactions in the podocyte expanded by STRING(Mus musculus), WP2309; Hypothetical Network for Drug Addiction(Homo sapiens), WP666 |
|---|